RYTM Prakiraan wutah bathi kanggo taun ngarep rhythmtx.com
Rhythm Pharmaceuticals bases its peptide production on the capacities of contract manufacturing organizations, relying on global supply chains. The projection of the expected EPS growth rate demonstrates profit dynamics, where the value of 79.10 characterizes this level. Rhythm Pharmaceuticals outsources clinical trials and distribution to external partners, while strict regulations on the air transport of orphan drugs guarantee stable access to medications across global markets.
RYTM (rhythmtx.com): rincian analitis lan laporan miturut indikator
- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi pasar:
- indikator kapitalisasi buku:
- informasi babagan utang lan solvabilitas:
Total Utang marang Modal Rhythm Pharmaceuticals|RYTM - Rasio tanggungan utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Rhythm Pharmaceuticals, Inc.|RYTM - Gunggung kewajiban utang perusahaan|Rasio utang marang kapitalisasi buku Rhythm Pharmaceuticals|RYTM - Kewajiban jangka dawa perusahaan|Utang jangka cendhak perusahaan Rhythm Pharmaceuticals|Rasio cepet rhythmtx.com
- data bathi resik lan rasio valuasi:
RYTM - Bathi pungkasan|Bathi mangsa ngarep Rhythm Pharmaceuticals|RYTM - Kapitalisasi marang bathi|Prakiraan rega marang bathi Rhythm Pharmaceuticals|RYTM - Rasio nilai perusahaan marang wutah bathi|Pangali EV/EBITDA Rhythm Pharmaceuticals|RYTM - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Rhythm Pharmaceuticals|RYTM - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan rhythmtx.com|RYTM - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Rhythm Pharmaceuticals
Analisis wiwitan perusahaan:RYTM, Rhythm Pharmaceuticals Inc
Retaining a core of experts in genetic metabolism allows Rhythm Pharmaceuticals (RYTM) to scale its workforce for commercialization, which directly impacts consensus earnings forecasts. By analyzing this chart of expected EPS growth over 12 months, investors assess the trend of net income per share revisions, determining the business model's sensitivity to market changes and the risk of capital drawdown should analyst expectations decline.
Analisis perusahaan pesaing
ASND (Ascendis Pharma Inc.) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep Madrigal Corp|Prakiraan wutah bathi kanggo taun ngarep CORT|Prakiraan wutah bathi resik saben saham kanggo taun ngarep AKRO (akerotx.com)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Metsera MTSR|MoonLake Immunotherapeutics AG (MLTX) - Prakiraan wutah bathi resik saben saham ing taun ngarep|CRNX - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|NAMS: Prakiraan wutah bathi resik saben saham kanggo taun ngarep|SLNO: Prakiraan wutah bathi kanggo taun ngarep|FOLD - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep 89bio|Agios (AGIO) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Structure Pharma (GPCR)|Prakiraan wutah bathi saben saham kanggo taun ngarep MiMedx Corp MDXG|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Rezolute, Inc. RZLT|Dinamika bathi saben saham sing diarepake ing taun ngarep LXRX|MBX Biosciences - Prakiraan wutah bathi kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep ALT (Altimmune Inc)|AARD (Aardvark Therapeutics Corp) - Prakiraan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Sagimet Biosciences Inc (SGMT)|Prakiraan wutah bathi saben saham kanggo taun ngarep BIOA|BMEA (biomeafusion.com) - Proyeksi tambahing bathi saben saham ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep QNCX|GUTS (Fractyl Health Inc.) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep vTv Therapeutics VTVT|ATPC - Prakiraan wutah bathi saben saham kanggo taun ngarep|PLUR: Prakiraan wutah bathi saben saham kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep SYBX (Synlogic, Inc.)|Lipocine (LPCN) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep MTNB (Matinas BioPharma Holdings)|SPRB (Spruce Biosciences, Inc.) - Prakiraan wutah bathi kanggo taun ngarep|GLTO: Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep CTCX|Prakiraan wutah bathi kanggo taun ngarep lumos-pharma.com (LUMO)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Organovo ONVO|Dinamika bathi saben saham sing diarepake ing taun ngarep RDUS
